Insider screener

Period: 12 months Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

36,752 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

36,752 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

36,752 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

36,752 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
36,752 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
36,752 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

36,752 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
23 Feb 2026
Davis John E Chief Commercial Officer
Sold at will
$141.82K 3,773 at 37.59
1.9%
Not planned
23 Feb 2026
Sold at will
$141.50K 566 at 250.00
11.5%
Not planned
23 Feb 2026
Sold at will
$140.95K 5,000 at 28.19
0.8%
Not planned
23 Feb 2026
ANDERSON ERIK J Director · indirect
Sold at will
$138.22K 10,000 at 13.82
1.4%
Not planned
23 Feb 2026
Bought
$135.43K 15,200 at 8.91
0.1%
Largest buy in 3 yrs
23 Feb 2026
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR
Sold at will
$130.86K 3,117 at 41.98
4.6%
Not planned
23 Feb 2026
Colburn Richard Edward III Chief Product & Tech Officer
Sold at will
$129.80K 2,500 at 51.92
30.2%
Not planned
23 Feb 2026
Burns Kristie Sr. VP Mktg & Clinical Affairs
Sold at will 2×
$125.61K 4,439 at 28.30
4.8%
Not planned
23 Feb 2026
Szela Mary T CEO and President
Bought
$125.00K 30,487 at 4.10
4.1%
Largest buy in 3 yrs
23 Feb 2026
Valle William Director
Bought
$125.00K 30,487 at 4.10
opened
First buy on file
23 Feb 2026
Holloway Jean F SVP, General Counsel
Sold at will
$115.73K 3,079 at 37.59
2.0%
Not planned
23 Feb 2026
CORRIGAN JACK E Director · indirect
Bought 8×
$114.78K 5,000 at 22.96
34.2%
+34% of stake
23 Feb 2026
LEE SANG YOUNG Director · indirect
Bought 2×
$112.40K 5,000 at 22.48
0.3%
23 Feb 2026
JOHNSON DAVID LEE Chief Operating Officer
Sold at will
$108.28K 2,579 at 41.98
5.3%
Not planned
23 Feb 2026
Gomez Fabian President
Sold at will
$100.94K 6,223 at 16.22
4.8%
Not planned
23 Feb 2026
CROWELL GAYLE A Director
Bought
$100.32K 6,600 at 15.20
8.2%
23 Feb 2026
Laponis Adam Chief Financial Officer
Sold at will
$97.39K 2,085 at 46.71
1.6%
Not planned
23 Feb 2026
Bought
$94.30K 10,000 at 9.43
62.6%
+63% of stake
23 Feb 2026
Bowman Erica S VICE PRESIDENT
Sold at will
$94.26K 1,276 at 73.88
28.4%
Not planned
23 Feb 2026
Turner William D. Chief Regulatory Officer
Sold at will
$91.82K 2,187 at 41.98
4.6%
Not planned
23 Feb 2026
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will
$91.08K 2,423 at 37.59
5.3%
Not planned
23 Feb 2026
Brenner Robert Chief Medical Officer
Sold at will
$90.31K 2,151 at 41.98
4.1%
Not planned
23 Feb 2026
Sold at will 5×
$89.48K 2,628 at 34.05
34.9%
Not planned
23 Feb 2026
Lockridge Matthew Head, U.S. Value Inv.
Sold at will
$87.25K 5,379 at 16.22
6.5%
Not planned
23 Feb 2026
WERNER ROBERT F. Chief Accounting Officer
Sold at will
$79.08K 1,693 at 46.71
3.0%
Not planned
23 Feb 2026
Sold at will
$78.07K 6,500 at 12.01
0.2%
Not planned
23 Feb 2026
Wilkinson Allen SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$72.61K 248 at 292.79
37.7%
Not planned
23 Feb 2026
Sold at will
$69.02K 2,000 at 34.51
0.0%
Not planned
23 Feb 2026
Green Paula SVP of Human Resources
Sold at will
$68.43K 1,465 at 46.71
1.2%
Not planned
23 Feb 2026
John Minardo Chief Legal Officer
Sold at will
$66.44K 17,439 at 3.81
4.4%
Not planned
23 Feb 2026
Skelton Laurence Matthew Chief Commercial Officer
Sold at will
$66.42K 1,582 at 41.98
2.4%
Not planned
23 Feb 2026
Horton Amy VP, Chief Accounting Officer
Sold at will
$65.06K 1,731 at 37.59
1.3%
Not planned
23 Feb 2026
Titinger Jorge Director
Sold at will
$60.13K 1,200 at 50.11
7.9%
Not planned
23 Feb 2026
Shetzline Michael SVP, CMO, Head-Res&Drug
Sold at will
$59.32K 15,570 at 3.81
2.8%
Not planned
23 Feb 2026
Sold at will
$58.36K 600 at 97.26
12.4%
Not planned
23 Feb 2026
BENHAM DOUGLAS N Director
Bought
$58.30K 2,000 at 29.15
6.2%
23 Feb 2026
Teel Randy President and CEO
Sold at will 2×
$58.20K 4,786 at 12.16
3.1%
Not planned
23 Feb 2026
Sold at will
$55.85K 2,500 at 22.34
29.4%
Not planned
23 Feb 2026
Ladhani Holli C. Director
Bought
$50.00K 3,600 at 13.89
opened
First buy on file
23 Feb 2026
Bought
$49.37K 7,016 at 7.04
0.3%
23 Feb 2026
Mazzariello Gina Chief Legal Officer
Sold at will
$48.35K 3,419 at 14.14
2.4%
Not planned
23 Feb 2026
Glickman Sarah JS Chief Financial Officer
Sold at will
$47.00K 2,796 at 16.81
0.8%
Not planned
23 Feb 2026
SWETS LARRY G JR Director
Bought
$47.00K 100,000 at 0.47
opened
First buy on file
23 Feb 2026
Schweihs Carl EVP and CFO
Bought
$46.50K 12,500 at 3.72
4.5%
23 Feb 2026
Forbes Murray III Chief Financial Officer
Sold at will
$46.37K 2,859 at 16.22
4.2%
Not planned
23 Feb 2026
Silver Ronald Principal Accounting Officer
Sold at will
$44.01K 11,552 at 3.81
4.2%
Not planned
23 Feb 2026
Cacace Angela M Chief Scientific Officer
Sold at will 2×
$43.89K 3,609 at 12.16
2.4%
Not planned
23 Feb 2026
Linton David O Head of Distribution
Sold at will
$43.05K 2,654 at 16.22
8.3%
Not planned
23 Feb 2026
Chao Xingjuan President and CEO
Sold at will
$41.24K 2,084 at 19.79
0.3%
Not planned
23 Feb 2026
CAPPELLO ALEXANDER L Director · indirect
Sold at will
$40.47K 635 at 63.74
9.3%
Not planned
Showing 24,801–24,850 of 36,752. ← Newer Page 497 of 736 Older →